uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Rotigotine Mylan
Application withdrawn
Human
Details
EMA number
EMEA/H/C/004286
ATC code
N04BC09
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of idiopathic Restless Legs Syndrome and Parkinson's disease.
MeSH:
Restless Legs Syndrome;Parkinson Disease
Active substances
rotigotine
Marketing Authorisation Holder
Mylan S.A.S.
MAH
Rotigotine Mylan | uMedical